GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helixmith Co Ltd (XKRX:084990) » Definitions » Institutional Ownership

Helixmith Co (XKRX:084990) Institutional Ownership : 3.66% (As of Mar. 02, 2025)


View and export this data going back to 2005. Start your Free Trial

What is Helixmith Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Helixmith Co's institutional ownership is 3.66%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Helixmith Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Helixmith Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Helixmith Co Institutional Ownership Historical Data

The historical data trend for Helixmith Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helixmith Co Institutional Ownership Chart

Helixmith Co Historical Data

The historical data trend for Helixmith Co can be seen below:

2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31
Institutional Ownership 3.48 3.47 4.21 4.16 4.15 4.07 3.97 3.89 3.86 3.66

Helixmith Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Helixmith Co Business Description

Traded in Other Exchanges
N/A
Address
1 Gwanak-ro, Gwanak-gu, 5th Floor, Building Number 203, Seoul National University, Seoul, KOR, 08826
Helixmith Co Ltd, formerly ViroMed Co Ltd is active in the healthcare sector in Korea. The company specializes in developing pharmaceutical products for the treatment of diseases related to peripheral artery, coronary artery, cardiovascular system and neuropathy, cancer and allergy. Its suite of products includes protein/deoxyribonucleic acid (DNA)-based biopharmaceuticals, botanical drugs and natural pharmaceuticals.

Helixmith Co Headlines

No Headlines